A new scanner developed by scientists at the University of Aberdeen could change the way breast cancer is diagnosed and ...
At December 31, 2024, the Company's cash and cash equivalents grew to $912.8 million, compared to $713.7 million at December 31, 2023, which accounts for approximately $100.0 million of repurchased ...
An advanced diagnostic machine used to detect critical diseases may soon be available closer to home for Clare patients. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback